VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)
Recruiting now · Not applicable
Conditions studied: Yellow Fever Vaccine
In brief
The aim of this study is to compare the immunogenicity induced by yellow fever vaccination administered during pregnancy with that induced by vaccination outside pregnancy, and to assess the maternal and fetal tolerance of this vaccination.
Key facts
- Study ID
- NCT06694766
- Run by
- Institut Pasteur
- People needed
- 270
- Starts
- 2025-03-24
- Expected to finish
- 2030-03-01
- Last updated by the study team
- 2025-12-15
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Common :
- Person over 18 years of age at the time of the first yellow fever vaccination
- Female gender
- Oral consent obtained after subject has been informed
- Subject covered by Social Security with the exception of Aide Médicale d'Etat
- Specific to both groups :
- For women vaccinated during pregnancy (case): Primary yellow fever vaccination during pregnancy
- For women vaccinated outside pregnancy (control): Primary yellow fever vaccination outside pregnancy
You may not qualify if…
- Criteria common to both sections (tolerance and immunogenicity):
- Subject having received a second yellow fever vaccination
- Persons unable to give informed consent for participation
- Women born in areas where yellow fever is endemic
- Female adults under legal protection (guardianship or trusteeship)
- Specific criteria for participants in the immunogenicity section:
- Medical condition imcompatible with 18.5 mL blood
- Women who have not given written consent to participate in the study. immunogenicity
Where it is running
- Medical Center of Institut Pasteur — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.